about
The Stearoyl-CoA Desaturase-1 (Desat1) in Drosophila cooperated with Myc to Induce Autophagy and Growth, a Potential New Link to Tumor SurvivalTumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.Retroperitoneal pararenal isolated neurofibroma: report of a case and review of literature.Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy.The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients.Tumor infiltrating lymphocytes in early breast cancer.Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.Solitary thyroid metastasis from colon cancer: a rare case report.Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.The clinical relevance of micropapillary carcinoma of the breast: a case-control study.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaPrognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer.Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IPrognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapyAnalysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and EliteEnhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerSalivary gland choristoma in large bowelTumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast CancersOncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 PatientsTowards mm-wave spectroscopy for dielectric characterization of breast surgical marginsDuctal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series
P50
Q33737444-28D3A098-E9E0-4BC3-B118-ECC11909E16DQ37160109-CF136F4B-A520-4266-8A82-FD3DE16E6D1DQ38015373-D315209E-F22B-4301-A08C-2A453D4E1D34Q38763570-47CE9BEB-5760-4F93-96BA-BBBBC9100618Q38828948-D946E543-DE52-4560-AC7F-CFAC24118DAAQ38959633-15C59C72-0363-43A7-83CE-83E675BC891AQ39211897-D4D980D5-B344-4C9D-AC60-B33713A330ECQ40284336-B76AC1CE-6BD0-4EAD-86EF-3D082F4EBBCDQ40807109-F3887A7A-0772-482C-B2BB-0C8B4375227DQ41375197-CB293D92-C5A3-4DD6-8A96-D4C360817F4CQ45248615-0FA2C46A-9F53-4D15-A866-D81699345B51Q46540302-D2B13D2A-BD35-4189-B4D6-FC7853F2C0E7Q47212593-B992E2EF-85E5-409C-B1FE-863BA8CB0A32Q52924405-BAF65F1E-F414-4995-8AF8-D8EA7F82DA4FQ54685474-18997AB9-DCD9-4B60-9A7B-4361AB54D12AQ60681783-33349501-18FB-4780-AE9A-18E31A6AEA5FQ60683159-2FF17F17-9D77-46F8-8949-64E2DE7AD4A6Q60683160-9217F9D0-2FB5-4FAD-A829-0EF3740C6876Q60683161-9FAFADAE-1351-46BB-9CBC-37A2D8CE198BQ62787702-41355381-8B00-4D07-9200-0E2D93A6CB72Q91501297-66DD875E-BD1A-4107-BD67-F303EC162EFCQ92448344-0A891CA6-4503-4DF2-BE41-2067B7477D5DQ92761710-9C50D74A-A2C9-4ADC-AB0C-FD329F0753AF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea Vingiani
@ast
Andrea Vingiani
@en
Andrea Vingiani
@es
Andrea Vingiani
@nl
type
label
Andrea Vingiani
@ast
Andrea Vingiani
@en
Andrea Vingiani
@es
Andrea Vingiani
@nl
prefLabel
Andrea Vingiani
@ast
Andrea Vingiani
@en
Andrea Vingiani
@es
Andrea Vingiani
@nl
P106
P1153
55052223400
P21
P31
P496
0000-0002-9827-3976